Background Although therapeutic guidelines recommend the use of neoadjuvant
chemotherapy before radical cystectomy (RC) in patients who have muscle-invasive bladder …

Background Neoadjuvant chemotherapy is underutilized in bladder cancer patients who
undergo radical cystectomy. However, the quality of regimens used in this setting remains …

Objective To determine whether neoadjuvant chemotherapy (NAC) is a predictor of
postoperative complications, length of stay (LOS), or operating time after radical cystectomy …

Purpose Several large, randomized, controlled trials provide evidence that neoadjuvant
chemotherapy improves the outcome of radical cystectomy for muscle invasive urothelial …

While it has been demonstrated that receipt of neoadjuvant chemotherapy (NAC) before
radical cystectomy (RC) improves survival compared to RC alone, the driving factor for this …

Adding chemotherapy to radical cystectomy (RC) may improve outcome. Neoadjuvant
treatment is advocated by guidelines based on meta-analysis data but is severely …

Objectives To compare perioperative and short-term postoperative complication rates
between patients receiving radical cystectomy (RC) after neoadjuvant chemotherapy (NAC) …

Background Neoadjuvant chemotherapy (NAC) is underutilized in the treatment of bladder
cancer (BC). Objective To investigate the effect of NAC on the risk of surgical complications …

Background Most patients with muscle-invasive bladder cancer (MIBC) developed
metastasis within 2 years, even after radical cystectomy (RC). The recurrence rate of MIBC …

Objectives: The purpose of this study was to investigate the impact of neoadjuvant
chemotherapy (NAC) on perioperative morbidity and on oncological outcomes according to …